Published in Acta Orthop on October 01, 2009
Mortality rates after incident non-traumatic fractures in older men and women. Osteoporos Int (2010) 1.46
In-hospital mortality after hip fracture by treatment setting. CMAJ (2016) 1.00
Analysis of the association between bisphosphonate treatment survival in Danish hip fracture patients-a nationwide register-based open cohort study. Osteoporos Int (2012) 0.92
Hip fractures in a geriatric population - rehabilitation based on patients needs. Aging Dis (2014) 0.77
Senior Managed Care System for Hip Fracture in the United States. Clin Orthop Surg (2016) 0.75
Hospital mortality after hip fracture surgery in relation to length of stay by care delivery factors: A database study. Medicine (Baltimore) (2017) 0.75
The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull (1999) 14.29
Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med (2007) 9.83
Epidemiology. When an entire country is a cohort. Science (2000) 7.93
Population-based study of survival after osteoporotic fractures. Am J Epidemiol (1993) 4.71
Selection of controls in case-control studies. I. Principles. Am J Epidemiol (1992) 3.94
Mortality associated with delay in operation after hip fracture: observational study. BMJ (2006) 3.82
Excess mortality attributable to hip fracture in white women aged 70 years and older. Am J Public Health (1997) 2.68
Race and sex differences in mortality following fracture of the hip. Am J Public Health (1992) 2.63
Prospective, multi-centre trial of mortality following general or spinal anaesthesia for hip fracture surgery in the elderly. Br J Anaesth (1987) 2.55
What is the true mortality of hip fractures? Public Health (1991) 2.52
Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev (2002) 2.49
Survival experience of aged hip fracture patients. Am J Public Health (1989) 2.46
Increased mortality in patients with a hip fracture-effect of pre-morbid conditions and post-fracture complications. Osteoporos Int (2007) 2.46
[The national patient registry. Evaluation of data quality]. Ugeskr Laeger (1995) 2.40
Survival and ambulation following hip fracture. J Bone Joint Surg Am (1978) 2.31
Mortality after hip fractures. Acta Orthop Scand (1979) 2.05
Mortality and life expectancy after hip fractures. Acta Orthop Scand (1980) 1.97
Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk--a meta-analysis. Osteoporos Int (2006) 1.79
Determinants of reduced survival following hip fractures in men. Clin Orthop Relat Res (1995) 1.69
Effectiveness of a multifaceted intervention on falls in nursing home residents. J Am Geriatr Soc (2003) 1.56
Hip fracture among the elderly in a mixed urban and rural population. Age Ageing (1984) 1.48
Meta-analyses of therapies for postmenopausal osteoporosis. III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis. Endocr Rev (2002) 1.44
Meta-analyses of therapies for postmenopausal osteoporosis. IV. Meta-analysis of raloxifene for the prevention and treatment of postmenopausal osteoporosis. Endocr Rev (2002) 1.34
Age and sex as determinants of mortality after hip fracture: 3,895 patients followed for 2.5-18.5 years. J Orthop Trauma (1993) 1.32
Hip protectors for preventing hip fractures in older people. Cochrane Database Syst Rev (2005) 1.31
The fixation and prognosis of trochanteric fractures. A randomized prospective controlled trial. Clin Orthop Relat Res (1990) 1.22
Mortality after cervical hip fracture. 3002 patients followed for 6 years. Acta Orthop Scand (1986) 1.22
Strontium ranelate for preventing and treating postmenopausal osteoporosis. Cochrane Database Syst Rev (2006) 1.19
The mortality and social prognosis of hip fractures. A prospective multifactorial study. Int Orthop (1994) 1.17
Ten-year survival after fractures of the proximal end of the femur. Gerontology (1988) 1.14
Effects of blood transfusion on clinical and functional outcomes in patients with hip fracture. Transfusion (2003) 1.05
Meta-analyses of therapies for postmenopausal osteoporosis. VI. Meta-analysis of calcitonin for the treatment of postmenopausal osteoporosis. Endocr Rev (2002) 1.02
Hemiarthroplasty in hip fracture care: effects of surgical volume on short-term outcome. J Arthroplasty (1998) 1.01
A meta-analysis of etidronate for the treatment of postmenopausal osteoporosis. Osteoporos Int (2001) 0.98
Fracture prevention in postmenopausal women. Clin Evid (2006) 0.77
Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ (2012) 5.63
Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 3.11
Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. JAMA (2008) 2.52
The effects of calcium supplementation on verified coronary heart disease hospitalization and death in postmenopausal women: a collaborative meta-analysis of randomized controlled trials. J Bone Miner Res (2015) 2.49
Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res (2011) 2.30
Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. JAMA (2004) 2.20
Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res (2003) 2.15
Fracture risk in patients with celiac Disease, Crohn's disease, and ulcerative colitis: a nationwide follow-up study of 16,416 patients in Denmark. Am J Epidemiol (2002) 2.05
Hip fracture patients at risk of second hip fracture: a nationwide population-based cohort study of 169,145 cases during 1977-2001. J Bone Miner Res (2009) 1.76
Fractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16,249 patients. Thyroid (2002) 1.66
Fracture risk associated with use of antiepileptic drugs. Epilepsia (2004) 1.55
Changes in 3-dimensional bone structure indices in hypoparathyroid patients treated with PTH(1-84): a randomized controlled study. J Bone Miner Res (2012) 1.54
The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism. Diabetes Care (2006) 1.52
High-dose treatment with vitamin A analogues and risk of fractures. Arch Dermatol (2010) 1.50
Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study. J Hypertens (2006) 1.48
Fracture risk in users of oral anticoagulants: a nationwide case-control study. Int J Cardiol (2006) 1.46
Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark. Osteoporos Int (2004) 1.43
Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials. J Clin Endocrinol Metab (2012) 1.42
The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study. J Bone Miner Res (2011) 1.42
Cardiovascular events before and after surgery for primary hyperparathyroidism. World J Surg (2003) 1.40
[Teriparatide (human recombinant 1-34 parathyroid hormone)--a new treatment regimen for severe osteoporosis]. Ugeskr Laeger (2004) 1.40
Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes. Calcif Tissue Int (2008) 1.40
[Denosumab--a new efficient osteoporosis therapy]. Ugeskr Laeger (2011) 1.39
Hyperthyroidism, bone mineral, and fracture risk--a meta-analysis. Thyroid (2003) 1.38
Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab (2014) 1.35
Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods. Clin Endocrinol (Oxf) (2008) 1.31
Fractures in patients with anorexia nervosa, bulimia nervosa, and other eating disorders--a nationwide register study. Int J Eat Disord (2002) 1.27
Nephrolithiasis and renal calcifications in primary hyperparathyroidism. J Clin Endocrinol Metab (2011) 1.24
Fracture risk associated with parkinsonism and anti-Parkinson drugs. Calcif Tissue Int (2007) 1.22
Gastric and esophagus events before and during treatment of osteoporosis. Calcif Tissue Int (2009) 1.22
Hypertension is a risk factor for fractures. Calcif Tissue Int (2008) 1.19
Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study. Arch Intern Med (2004) 1.18
Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study. BMJ (2002) 1.17
Has mortality after a hip fracture increased? J Am Geriatr Soc (2007) 1.16
Vitamin D and calcium supplementation prevents severe falls in elderly community-dwelling women: a pragmatic population-based 3-year intervention study. Aging Clin Exp Res (2005) 1.16
Vitamin D status in Greenland is influenced by diet and ethnicity: a population-based survey in an Arctic society in transition. Br J Nutr (2012) 1.14
Selective serotonin reuptake inhibitors and other antidepressants and risk of fracture. Calcif Tissue Int (2008) 1.10
Increased plasma concentrations of vitamin D metabolites and vitamin D binding protein in women using hormonal contraceptives: a cross-sectional study. Nutrients (2013) 1.09
Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study. Bone (2007) 1.07
PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatment. J Bone Miner Res (2013) 1.06
Intake of vitamin D and risk of breast cancer--a meta-analysis. J Steroid Biochem Mol Biol (2008) 1.06
Smoking as a risk factor for Graves' disease, toxic nodular goiter, and autoimmune hypothyroidism. Thyroid (2002) 1.05
Trends in incidence and mortality in the hospital diagnosis of atrial fibrillation or flutter in Denmark, 1980-1999. Int J Cardiol (2005) 1.04
Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism. BMJ (2003) 1.03
Loop diuretics increase bone turnover and decrease BMD in osteopenic postmenopausal women: results from a randomized controlled study with bumetanide. J Bone Miner Res (2005) 1.03
Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women. J Bone Miner Res (2004) 1.03
Osteoarthritis and risk of fractures. Calcif Tissue Int (2009) 1.02
Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev (2009) 1.01
Postsurgical hypoparathyroidism--risk of fractures, psychiatric diseases, cancer, cataract, and infections. J Bone Miner Res (2014) 0.99
Hip fracture risk in statin users--a population-based Danish case-control study. Osteoporos Int (2004) 0.99
Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial. J Clin Endocrinol Metab (2014) 0.98
Decreased fracture risk in users of organic nitrates: a nationwide case-control study. J Bone Miner Res (2006) 0.98
Determinants of plasma PTH and their implication for defining a reference interval. Clin Endocrinol (Oxf) (2011) 0.97
Fracture risk in perimenopausal women treated with beta-blockers. Calcif Tissue Int (2004) 0.96
Fractures in patients with primary hyperparathyroidism: nationwide follow-up study of 1201 patients. World J Surg (2003) 0.96
Maxillary distraction osteogenesis in a patient with pycnodysostosis: a case report. J Oral Maxillofac Surg (2004) 0.96
Simvastatin does not affect vitamin d status, but low vitamin d levels are associated with dyslipidemia: results from a randomised, controlled trial. Int J Endocrinol (2009) 0.96
Are antiresorptive drugs effective against fractures in patients with diabetes? Calcif Tissue Int (2010) 0.95
Molecular genetic analysis of the calcium sensing receptor gene in patients clinically suspected to have familial hypocalciuric hypercalcemia: phenotypic variation and mutation spectrum in a Danish population. J Clin Endocrinol Metab (2007) 0.94
Body composition is distinctly altered in Turner syndrome: relations to glucose metabolism, circulating adipokines, and endothelial adhesion molecules. Eur J Endocrinol (2006) 0.94
The effects of depot medroxyprogesterone acetate and intrauterine device use on fracture risk in Danish women. Contraception (2008) 0.94
Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J Bone Miner Res (2013) 0.93
Effect of tamoxifen and aromatase inhibitors on the risk of fractures in women with breast cancer. Calcif Tissue Int (2008) 0.93
Familial hypocalciuric hypercalcaemia: a review. Curr Opin Endocrinol Diabetes Obes (2011) 0.93
Use of bisphosphonates and risk of breast cancer. Calcif Tissue Int (2011) 0.92
Emerging anabolic treatments in osteoporosis. Curr Drug Saf (2011) 0.91
Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism. Eur J Endocrinol (2008) 0.90
Fracture risk in patients with chronic lung diseases treated with bronchodilator drugs and inhaled and oral corticosteroids. Chest (2007) 0.90
Renal stones and calcifications in patients with primary hyperparathyroidism: associations with biochemical variables. Eur J Endocrinol (2012) 0.90
A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: longitudinal data from the Danish osteoporosis prevention study. J Bone Miner Res (2003) 0.90
Vitamin D status and bone and connective tissue turnover in brown bears (Ursus arctos) during hibernation and the active state. PLoS One (2011) 0.90
Correlates of falling during 24 h among elderly Danish community residents. Prev Med (2004) 0.89
Female premenopausal fracture risk is associated with gc phenotype. J Bone Miner Res (2004) 0.89